Back to Directory
Last Updated: 08/05/2026
MicroPharm
Wales
Founded 1998
Ovine polyclonal therapeutics developer and antivenom manufacturer
MicroPharm is a specialty pharmaceutical company developing and manufacturing ovine polyclonal antibody therapeutics for the treatment of acute toxic and infectious conditions.
The company's MHRA-licensed facilities in West Wales produce a portfolio of clinical-grade antivenoms, including products acquired from Sanofi Pasteur in 2024.
Pipeline assets include an orally delivered polyclonal antibody therapy for Clostridioides difficile infection currently in Phase I clinical development.
MicroPharm also provides contract development, manufacturing, and sterile filling services to third parties.